Exclusive Content
Jazz Pharmaceuticals to Acquire Actio Biosciences for Up to $1.32 Billion, Expanding Rare Epilepsy Portfolio
Jazz Pharmaceuticals plc and Actio Biosciences, Inc. announced a agreement under which Jazz will acquire privately held Actio Biosciences for $820 million in cash...
Seven Clinical Trial Ethics Panels Lose CDSCO Registration in Compliance Crackdown
The Central Drugs Standard Control Organisation (CDSCO) has withdrawn registration certificates from seven Ethics Committees nationwide after risk-based audits uncovered serious lapses under the...
From Research to Revolution: Novo Nordisk Shares Oral GLP-1 Breakthrough Story
Novo Nordisk has shared the scientific journey behind turning an injectable biologic medicine into a pill — a challenge researchers have wrestled with since...
Biozenta Lifescience to Build ₹1,250 Crore Oncology Plant in Barabanki, UP
Biozenta Lifescience Pvt. Ltd., a global leader in oncology medicines, has announced plans to establish a state-of-the-art manufacturing facility in Barabanki, Uttar Pradesh, marking a major milestone for...
Zydus Collaborates with ICMR to Address Sickle Cell Disease as Desidustat Enters Phase III
Zydus Lifesciences Limited, in collaboration with the Indian Council of Medical Research (ICMR), has announced the successful completion of Phase II Proof-of-Concept trials and approval...
VELMENI Secures FDA Nod for Advanced AI-Driven 3D Dental Imaging
Sunnyvale, California-based dental AI firm VELMENI announced on July 23, 2026, that the U.S. FDA has granted 510(k) clearance for its latest software, VELMENI...
